BRAVEHEART BIO INC

BRVE · NASDAQ

Updated at 2026-11-16 20:42:47

$19.22-2.03%
Today's High
$20.21
Today’s Low
$18.70
BRAVEHEART BIO INC (BRVE) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$20.41
Previous Close
$19.62
Volume
536.6K
Market Cap
$1.76B
P/E Ratio
--
EPS
$-1.24

Previous Day Range

$19.18$20.41

52-Week Range

$16.70$32.00

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
ONE LETTERMAN DRIVE, SAN FRANCISCO, CA, UNITED STATES, 94129
Country
US
Listing Date
2026-08-06
Fiscal Year End
December
Shares Outstanding
90.04M
CIK
0002131524

Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. The company is headquartered in San Francisco, California.

Financial Metrics

Revenue

2026-09-30

$0

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

Operating Expenses

2026-09-30

$30.14M

2026-06-30

$15.88M

2026-03-31

$14.84M

2025-12-31

$6.98M

Net Income

2026-09-30

-$26.49M

2026-06-30

-$14.98M

2026-03-31

-$14.28M

2025-12-31

-$6.45M

Net Profit Margin

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

Earnings Per Share

2026-09-30

$-0.51

2026-06-30

$-2.51

2026-03-31

--

2025-12-31

--

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

-$30.14M

2026-06-30

-$15.87M

2026-03-31

-$14.84M

2025-12-31

-$6.98M

Effective Tax Rate

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.